自身免疫性疾病的联合治疗：类风湿关节炎模型 - Suppr

Suppr

超能文献

Combination therapy for autoimmune diseases: the rheumatoid arthritis model.

作者信息

Fathy N, Furst D E

机构信息

Assiut University Hospital, Seattle, Washington, USA.

出版信息

Springer Semin Immunopathol. 2001;23(1-2):5-26. doi: 10.1007/s002810100063.

DOI:10.1007/s002810100063

PMID:11455861

Abstract

摘要

相似文献

Combination therapy for autoimmune diseases: the rheumatoid arthritis model.

Springer Semin Immunopathol. 2001;23(1-2):5-26. doi: 10.1007/s002810100063.

Update 2011: leflunomide in rheumatoid arthritis - strengths and weaknesses.

Curr Opin Rheumatol. 2011 May;23(3):282-7. doi: 10.1097/BOR.0b013e328344fddb.

Methotrexate: vital new information about a middle aged drug.

J Rheumatol. 2002 Oct;29(10):2031-3.

Rational disease-modifying anti-rheumatic drug (DMARD) therapy: is it possible?

Br J Rheumatol. 1996 Aug;35(8):707-8. doi: 10.1093/rheumatology/35.8.707.

Combination treatment in autoimmune diseases. Methodology of combination trials.

Springer Semin Immunopathol. 2001;23(1-2):27-33. doi: 10.1007/s002810100073.

TNFalpha antagonists in rheumatoid arthritis patients seen in everyday practice.

Joint Bone Spine. 2007 Dec;74(6):523-6. doi: 10.1016/j.jbspin.2007.10.002.

Comparative effectiveness of treatments for rheumatoid arthritis.

Ann Intern Med. 2008 Jan 15;148(2):162-3. doi: 10.7326/0003-4819-148-2-200801150-00012.

Two is better than one? Combination therapy in rheumatoid arthritis.

Rheumatology (Oxford). 2004 Oct;43(10):1205-7. doi: 10.1093/rheumatology/keh299. Epub 2004 Jun 29.

Flowchart: rheumatoid arthritis treatment.

Med Lett Drugs Ther. 2021 Nov 15;63(1637):e1.

The pharmacogenetics of methotrexate.

Rheumatology (Oxford). 2007 Oct;46(10):1520-4. doi: 10.1093/rheumatology/kem147. Epub 2007 Jun 24.

引用本文的文献

Pharmacovigilance of Herb-Drug Interactions: A Pharmacokinetic Study on the Combined Administration of Tripterygium Glycosides Tablets and Leflunomide Tablets in Rats by LC-MS/MS.

Pharmaceuticals (Basel). 2022 Aug 11;15(8):991. doi: 10.3390/ph15080991.

Combination treatment in autoimmune diseases. Methodology of combination trials.

Springer Semin Immunopathol. 2001;23(1-2):27-33. doi: 10.1007/s002810100073.

本文引用的文献

Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis.

Am J Med Sci. 1951 Feb;221(2):176-82.

The ocular complications of chloroquine therapy.

Lancet. 1958 Jun 7;1(7032):1207-9. doi: 10.1016/s0140-6736(58)91911-1.

Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis.

Arthritis Rheum. 2002 Jun;46(6):1460-9. doi: 10.1002/art.10307.

Benefits and risks of minocycline in rheumatoid arthritis.

Drug Saf. 2000 May;22(5):405-14. doi: 10.2165/00002018-200022050-00007.

Methotrexate suppresses the interleukin-6 induced generation of reactive oxygen species in the synoviocytes of rheumatoid arthritis.

Immunopharmacology. 2000 Apr;47(1):35-44. doi: 10.1016/s0162-3109(99)00185-x.

The pharmacokinetics of etanercept in healthy volunteers.

Ann Pharmacother. 2000 Feb;34(2):161-4. doi: 10.1345/aph.19126.

Leflunomide, mycophenolic acid and matrix metalloproteinase inhibitors.

Rheumatology (Oxford). 1999 Nov;38 Suppl 2:14-8.

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

Lancet. 1999 Dec 4;354(9194):1932-9. doi: 10.1016/s0140-6736(99)05246-0.

Etanercept and methotrexate combination therapy.

Clin Exp Rheumatol. 1999 Nov-Dec;17(6 Suppl 18):S69-72.

Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis.

Ann Rheum Dis. 1999 Nov;58 Suppl 1(Suppl 1):I56-60. doi: 10.1136/ard.58.2008.i56.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验